Dr Anna Jane Knisely, MD in Mount Vernon, WA - Medicare Otolaryngology

Dr Anna Jane Knisely, MD is a medicare enrolled "Otolaryngology" physician in Mount Vernon, Washington. She went to University Of Washington School Of Medicine and graduated in 2009 and has 15 years of diverse experience with area of expertise as Otolaryngology. She is a member of the group practice King County Public Hospital District No 2, Southeast Alaska Regional Health Consortium and her current practice location is 111 S 13th St, Mount Vernon, Washington. You can reach out to her office (for appointments etc.) via phone at (360) 336-2178.

Dr Anna Jane Knisely is licensed to practice in Washington (license number MD60573979) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1992937825.

Contact Information

	Dr Anna Jane Knisely, MD
	111 S 13th St, Mount Vernon, WA 98274-4105
	(360) 336-2178
	(360) 336-2642

Physician's Profile

Full Name	Dr Anna Jane Knisely
Gender	Female
Speciality	Otolaryngology
Experience	15 Years
Location	111 S 13th St, Mount Vernon, Washington
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Anna Jane Knisely attended and graduated from University Of Washington School Of Medicine in 2009

NPI Data:

NPI Number: 1992937825
Provider Enumeration Date: 08/11/2009
Last Update Date: 08/26/2015

Medicare PECOS Information:

PECOS PAC ID: 7719287622
Enrollment ID: I20151125001682

Medical Identifiers

Medical identifiers for Dr Anna Jane Knisely such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1992937825	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	MT195895 (Pennsylvania)	Secondary
207Y00000X	Otolaryngology	MD60573979 (Washington)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Mt Edgecumbe Hospital	Sitka, AK	Hospital
Evergreenhealth Medical Center	Kirkland, WA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
King County Public Hospital District No 2	7618880097	481
Southeast Alaska Regional Health Consortium	1456265362	226

News Archive

People with prior mental health problems more severely affected during the pandemic

People who had higher pre-pandemic levels of depression or anxiety have been more severely affected by disruption to jobs and healthcare during the pandemic, according to a new study co-led by UCL researchers.

Discovery of a new gene that stimulates the growth of natural bypasses

World Congress of Cardiology Report - Researchers from the Max-Planck-Institute for Heart and Lung Research (MPI) in Bad Nauheim, Germany, have identified a gene, whose therapeutic use may be beneficial for patients suffering from obstructive arterial diseases.

Cymbalta approved for fibromyalgia

The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly and Company announced.

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Anna Jane Knisely allows following entities to bill medicare on her behalf.

Entity Name	King County Public Hospital District No 2
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1801986070 PECOS PAC ID: 7618880097 Enrollment ID: O20031111000557

News Archive

People with prior mental health problems more severely affected during the pandemic

Discovery of a new gene that stimulates the growth of natural bypasses

Cymbalta approved for fibromyalgia

The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly and Company announced.

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Entity Name	Swedish Health Services
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1689612954 PECOS PAC ID: 0244138196 Enrollment ID: O20031230000187

People with prior mental health problems more severely affected during the pandemic

Discovery of a new gene that stimulates the growth of natural bypasses

Cymbalta approved for fibromyalgia

The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly and Company announced.

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Anna Jane Knisely is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Anna Jane Knisely, MD 805 Madison St, Suite 901, Seattle, WA 98104-1172 Ph: (206) 264-8100	Dr Anna Jane Knisely, MD 111 S 13th St, Mount Vernon, WA 98274-4105 Ph: (360) 336-2178

News Archive

People with prior mental health problems more severely affected during the pandemic

Discovery of a new gene that stimulates the growth of natural bypasses

Cymbalta approved for fibromyalgia

The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly and Company announced.

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Otolaryngology Doctors in Mount Vernon, WA

James R Gross, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 118 S 12th St, Mount Vernon, WA 98274 Phone: 360-336-2178 Fax: 360-336-1995
Dr. Christopher Ray England, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 118 S 12th St, Mount Vernon, WA 98274 Phone: 360-336-2178 Fax: 360-336-1995
Dr. Michael Bryan Mullen, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 118 S 12th St, Mount Vernon, WA 98274 Phone: 360-336-2178 Fax: 360-336-1995
Gary L Brown, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 118 S 12th St, Mount Vernon, WA 98274 Phone: 360-336-2178 Fax: 360-336-1995
Gary K Johnson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 118 S 12th St, Mount Vernon, WA 98274 Phone: 360-336-2178 Fax: 360-336-1995
Dr. Jonathan R Grant, MD Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 111 S 13th St, Mount Vernon, WA 98274 Phone: 360-336-2178 Fax: 360-336-1674

Dr Anna Jane Knisely, MD - Medicare Otolaryngology in Mount Vernon, WA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

People with prior mental health problems more severely affected during the pandemic

Discovery of a new gene that stimulates the growth of natural bypasses

Cymbalta approved for fibromyalgia

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Medicare Reassignments

People with prior mental health problems more severely affected during the pandemic

Discovery of a new gene that stimulates the growth of natural bypasses

Cymbalta approved for fibromyalgia

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

People with prior mental health problems more severely affected during the pandemic

Discovery of a new gene that stimulates the growth of natural bypasses

Cymbalta approved for fibromyalgia

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

People with prior mental health problems more severely affected during the pandemic

Discovery of a new gene that stimulates the growth of natural bypasses

Cymbalta approved for fibromyalgia

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Otolaryngology Doctors in Mount Vernon, WA